Medirom Healthcare Company Leadership
| MRM Stock | USD 1.38 0.01 0.72% |
Medirom Healthcare employs about 334 people. The company is managed by 3 executives with a total tenure of roughly 780 years, averaging almost 260.0 years of service per executive, having 111.33 employees per reported executive. Analysis of Medirom Healthcare's management performance can provide insight into the firm performance.
Medirom Healthcare Management Team Effectiveness
At this time, Medirom Healthcare's Return On Tangible Assets are very stable compared to the past year. As of the 21st of July 2025, Return On Assets is likely to grow to 0.02, while Return On Capital Employed is likely to drop (0). At this time, Medirom Healthcare's Intangible Assets are very stable compared to the past year. As of the 21st of July 2025, Return On Tangible Assets is likely to grow to 0.02, though Net Tangible Assets are likely to grow to (1 B). Medirom Healthcare's management efficiency ratios could be used to measure how well Medirom Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.As of the 21st of July 2025, Common Stock Shares Outstanding is likely to drop to about 5.4 M. In addition to that, Net Loss is likely to grow to about (847.1 M)
Medirom Healthcare Workforce Comparison
Medirom Healthcare Technologies is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 925. Medirom Healthcare totals roughly 334 in number of employees claiming about 36% of equities under Health Care industry.
Medirom Healthcare Profit Margins
The company has Net Profit Margin of 0.02 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.13 %, which entails that for every 100 dollars of revenue, it generated $0.13 of operating income.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.19 | 0.2707 |
|
|
Medirom Healthcare Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medirom Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medirom Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Medirom Healthcare insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cohen Edward H over six months ago Disposition of 2500 shares by Cohen Edward H of Medirom Healthcare at 11.18 subject to Rule 16b-3 | ||
Cohen Edward H over a year ago Disposition of 2500 shares by Cohen Edward H of Medirom Healthcare at 9.78 subject to Rule 16b-3 |
Medirom Healthcare Notable Stakeholders
A Medirom Healthcare stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medirom Healthcare often face trade-offs trying to please all of them. Medirom Healthcare's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medirom Healthcare's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Akira Aoki | Executive Officer | Profile | |
| Fumitoshi Fujiwara | CFO Director | Profile | |
| Kouji Eguchi | CEO Director | Profile |
About Medirom Healthcare Management Performance
The success or failure of an entity such as Medirom Healthcare often depends on how effective the management is. Medirom Healthcare management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medirom management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medirom management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.16 | 0.15 |
Medirom Healthcare Workforce Analysis
Traditionally, organizations such as Medirom Healthcare use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medirom Healthcare within its industry.Medirom Healthcare Manpower Efficiency
Return on Medirom Healthcare Manpower
| Revenue Per Employee | 24.8M | |
| Revenue Per Executive | 2.8B | |
| Net Income Per Employee | 413.7K | |
| Net Income Per Executive | 46.1M |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.278 | Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth 0.312 | Return On Assets |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.